申请人:LEK PHARMACEUTICALS D.D.
公开号:US20140187558A1
公开(公告)日:2014-07-03
The invention relates to the preparation of chiral compounds, in particular to the preparation of chiral compounds which may be used as intermediates for the preparation of anti-diabetic agents, preferably sitagliptin.
该发明涉及手性化合物的制备,特别是涉及可用作抗糖尿病药物中间体制备的手性化合物的制备,最好是西他列汀。